… a short description of the clinical presentation of patients with osteoporosis and the development
of … between clinical appearance of osteoporosis and its underlying cellular mechanisms. …

… current molecular and genetic opinions on osteoporosis and its medical treatment. It offers
… and clinicians with osteoporosis assessment. However, many issues regarding osteoporosis …

… of osteoporosis, when and how to start treatment, and appropriate therapy and monitoring. …
the 10-year incidence of hip and major osteoporotic fractures (clinical spine, forearm, hip, or …

… more effective therapeutic drugs based on the new pathogenesis of osteoporosis. In this
review, we summarize novel mechanisms involved in the pathological process of osteoporosis, …

… been reported for creating a novel therapy for osteoporosis. The identification of RANKL as
the final effector in the pathogenesis of osteoporosis has led to an improved understanding of …

… topic of safety of osteoporosis therapeutics has … osteoporosis therapies by Drs. Lianne Tile
and Angela Cheung. Despite the considerable benefit of our current osteoporosis therapeutics…

… need for newer therapeutics to treat osteoporosis, which can … effective and safe anti‐osteoporotic
agent. This review represents … in disease progression, available therapeutic options, the …

… or children, or as preventive therapy for osteoporosis; it should not be used in combination
with other pharmacological agents for osteoporosis. Because denosumab inhibits the binding …

… likelihood of osteoporosis, as older patients produce fewer stem cells with self-renewal and
immunomodulatory capacities [134]. Clinical therapies for the treatment of osteoporosis have …

… The osteoporotic elderly population could present an increased risk of … in osteoporotic
fractures, but the clinical studies remains controversial. Van Wunnik has shown that osteoporosis …